Nadia Brambilla

A nutraceutical combination reduces left ventricular mass in subjects with metabolic syndrome e and left ventricular hypertrophy: A multicenter, randomized, double-blind, placebo-controlled trial.

D. Bonaduce, M. D'Amato, G. Pucci, 2020, Clinical nutrition.

A first-in-human trial on the safety and immunogenicity of COVID-eVax, a cellular response-skewed DNA vaccine against COVID-19

P. Ascierto, F. Palombo, A. Manenti, 2022, Molecular Therapy.

Intravenous silibinin monotherapy shows significant antiviral activity in HCV-infected patients in the peri-transplantation period.

X. Forns, M. Navasa, M. D'Amato, 2013, Journal of hepatology.

T-48 Efficacy and safety of intravenous silibinin in patients with HCV recurrence on the graft after liver transplantation (LT): a prospective, randomized, double-blind, placebo-controlled pilot study

R. Bringiotti, M. D'Amato, A. Castellaneta, 2013 .

Antiviral activity and safety profile of silibinin in HCV patients with advanced fibrosis after liver transplantation: a randomized clinical trial

A. Di Leo, M. D'Amato, A. Castellaneta, 2014, Transplant international : official journal of the European Society for Organ Transplantation.

Efficacy of a nutraceutical combination on lipid metabolism in patients with metabolic syndrome: a multicenter, double blind, randomized, placebo controlled trial

D. Bonaduce, M. D'Amato, G. Pucci, 2019, Lipids in Health and Disease.

Efficacy and safety of the first-in-class imidazoline-2 receptor ligand CR4056 in pain from knee osteoarthritis and disease phenotypes: a randomized, double-blind, placebo-controlled phase 2 trial.

M. D'Amato, L. Rovati, G. Giacovelli, 2019, Osteoarthritis and cartilage.

Efficacy of a nutraceutical combination on lipid metabolism in patients with metabolic syndrome: a multicenter, double blind, randomized, placebo controlled trial

D. Bonaduce, M. D'Amato, G. Pucci, 2019, Lipids in Health and Disease.